NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,199 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,199 Papers indexed
1,440 Papers AI scored
40,199 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-07 10:15 AM
1 Social Determinants of Sleep Health in Survivors of Childhood Cancer: A Systematic Review. Journal of sleep research — Nov 07, 2026 2 Primitive neuroectodermal tumour of the left posterior mandible. BMJ case reports — Nov 07, 2026 3 Adrenal ganglioneuroma in an adolescent presenting as an incidentaloma: Imaging-pathology correlation and diagnostic challenges: A case report. Medicine — Nov 07, 2026 4 Synchronous hepatocellular carcinoma and nasopharyngeal carcinoma in a patient with chronic hepatitis B: A case report and literature review. Medicine — Nov 07, 2026 5 Prenatal Trio Exome Sequencing in Low-Risk Pregnancies: Diagnostic Yield and Clinical Implications. Clinical genetics — Nov 07, 2026 6 Defining and validating an HPV vaccination motivation score in Kenya and Malawi: A tool for use in low- and middle-income countries. Vaccine — Nov 07, 2026 7 Drawing the Sacred: Visualizing Where Hope Lives in Hispanic Adolescent and Young Adult Cancer Survivorship. Journal of adolescent and young adult oncology — Nov 07, 2026 8 Social Isolation in Japanese Adolescents and Young Adults with Hematologic Malignancies: A Focus on Peer Relationships and Occupational Therapy Implications. Journal of adolescent and young adult oncology — Nov 07, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40199 results
C
A Rare Case of Benign-Appearing Myoepithelial Carcinoma of the Hard Palate in an Adolescent.
PMID 42882169 Published: 2026-10-06 Ingested: 2026-10-18 09:15 AM Journal of clinical medicine
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Tissue Preservation and FFPE Samples: Optimized Nucleic Acids Isolation in Ewing Sarcoma.
PMID 42879008 Published: 2027-01-01 Ingested: 2026-10-17 09:15 AM Methods in molecular biology (Clifton, N.J.)
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
A mixed methods examination of caregiver perspectives on the quality of life and executive functioning of young childhood cancer survivors.
PMID 42867985 Published: 2026-10-13 Ingested: 2026-10-15 09:15 AM Journal of psychosocial oncology
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

C
Spirituality in Multicultural Pediatric Oncology End-of-Life Care: Four Cases.
PMID 42861447 Published: 2026-10-12 Ingested: 2026-10-14 09:15 AM Clinical pediatrics
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Cesarean Delivery after Abdominal Wall Reconstruction Using an Anterolateral Thigh Flap with Vascularized Fascia Lata.
PMID 42857763 Published: 2026-10-09 Ingested: 2026-10-13 09:15 AM Plastic and reconstructive surgery. Global open
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Distribution of molecular subtypes in a Colombian cohort of patients with acute lymphoblastic leukemia using whole-transcriptome analysis.
PMID 42845834 Published: 2026-09-23 Ingested: 2026-10-10 09:15 AM Frontiers in oncology
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Age- and latency-specific patterns of subsequent malignant brain and other nervous system tumors after cancer diagnosed before age 40 years.
PMID 42839191 Published: 2026-10-07 Ingested: 2026-10-09 09:15 AM Cancer causes & control : CCC
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Prenatal Ultrasound and MRI Findings in Two Fetuses With Perineal Lipoma.
PMID 42836542 Published: 2026-01-01 Ingested: 2026-10-08 09:15 AM Congenital anomalies
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Focal periphyseal edema with atypical MRI features: Biopsy findings and imaging follow-up.
PMID 42827646 Published: 2026-09-21 Ingested: 2026-10-06 09:15 AM Radiology case reports
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
The Expanding Spectrum of DICER1-Associated Gynecologic Neoplasms.
PMID 42817922 Published: 2026-10-01 Ingested: 2026-10-03 09:15 AM Advances in anatomic pathology
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Beyond standard care: Fathers' perspectives on healthcare and related support services when caring for a child with a progressive life-limiting condition-A qualitative study.
PMID 42811452 Published: 2026-09-29 Ingested: 2026-10-02 09:15 AM Palliative medicine
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 2488 of 3350
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic